Literature DB >> 32641828

Envelope protein ubiquitination drives entry and pathogenesis of Zika virus.

Maria I Giraldo1,2, Hongjie Xia3, Leopoldo Aguilera-Aguirre1, Adam Hage1, Sarah van Tol1, Chao Shan3, Xuping Xie3, Gail L Sturdevant4, Shelly J Robertson4, Kristin L McNally4, Kimberly Meade-White4, Sasha R Azar1,5,6, Shannan L Rossi6,7, Wendy Maury8, Michael Woodson9, Holly Ramage10, Jeffrey R Johnson11,12,13,14, Nevan J Krogan11,12,13,14, Marc C Morais3,9, Sonja M Best4, Pei-Yong Shi15,16,17,18,19, Ricardo Rajsbaum20,21.   

Abstract

Zika virus (ZIKV) belongs to the family Flaviviridae, and is related to other viruses that cause human diseases. Unlike other flaviviruses, ZIKV infection can cause congenital neurological disorders and replicates efficiently in reproductive tissues1-3. Here we show that the envelope protein (E) of ZIKV is polyubiquitinated by the E3 ubiquitin ligase TRIM7 through Lys63 (K63)-linked polyubiquitination. Accordingly, ZIKV replicates less efficiently in the brain and reproductive tissues of Trim7-/- mice. Ubiquitinated E is present on infectious virions of ZIKV when they are released from specific cell types, and enhances virus attachment and entry into cells. Specifically, K63-linked polyubiquitin chains directly interact with the TIM1 (also known as HAVCR1) receptor of host cells, which enhances virus entry in cells as well as in brain tissue in vivo. Recombinant ZIKV mutants that lack ubiquitination are attenuated in human cells and in wild-type mice, but not in live mosquitoes. Monoclonal antibodies against K63-linked polyubiquitin specifically neutralize ZIKV and reduce viraemia in mice. Our results demonstrate that the ubiquitination of ZIKV E is an important determinant of virus entry, tropism and pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32641828      PMCID: PMC7501154          DOI: 10.1038/s41586-020-2457-8

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  1 in total

1.  Labeling membrane glycoproteins or glycolipids with fluorescent wheat germ agglutinin.

Authors:  Brad Chazotte
Journal:  Cold Spring Harb Protoc       Date:  2011-05-01
  1 in total
  31 in total

1.  Exploiting Ubiquitin Ligases for Induced Target Degradation as an Antiviral Strategy.

Authors:  Rati Verma
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  A C-terminal glutamine recognition mechanism revealed by E3 ligase TRIM7 structures.

Authors:  Xiao Liang; Jun Xiao; Xuzichao Li; Yujie Liu; Yao Lu; Yanan Wen; Zexing Li; Xing Che; Yongjian Ma; Xingyan Zhang; Yi Zhang; Deng Jian; Peihui Wang; Chenghao Xuan; Guimei Yu; Long Li; Heng Zhang
Journal:  Nat Chem Biol       Date:  2022-08-18       Impact factor: 16.174

3.  Selective Polyprotein Processing Determines Norovirus Sensitivity to Trim7.

Authors:  Meagan E Sullender; Linley R Pierce; Mridula Annaswamy Srinivas; Stacey L Crockett; Bria F Dunlap; Rachel Rodgers; Lawrence A Schriefer; Elizabeth A Kennedy; Brittany M Stewart; John G Doench; Megan T Baldridge; Robert C Orchard
Journal:  J Virol       Date:  2022-08-16       Impact factor: 6.549

4.  Enterovirus 3C Protease Cleaves TRIM7 To Dampen Its Antiviral Activity.

Authors:  Wenchun Fan; Matthew B McDougal; John W Schoggins
Journal:  J Virol       Date:  2022-09-15       Impact factor: 6.549

5.  Identification and characterization of key residues in Zika virus envelope protein for virus assembly and entry.

Authors:  Xiao Ma; Zhenghong Yuan; Zhigang Yi
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

Review 6.  Dual-Role Ubiquitination Regulation Shuttling the Entire Life Cycle of the Flaviviridae.

Authors:  Dongjie Cai; Lingli Liu; Bin Tian; Xingxin Fu; Qiyuan Yang; Jie Chen; Yilin Zhang; Jing Fang; Liuhong Shen; Ya Wang; Liping Gou; Zhicai Zuo
Journal:  Front Microbiol       Date:  2022-05-06       Impact factor: 6.064

7.  Crystal structure and mutational analysis of the human TRIM7 B30.2 domain provide insights into the molecular basis of its binding to glycogenin-1.

Authors:  Christian J Muñoz Sosa; Federico M Issoglio; María E Carrizo
Journal:  J Biol Chem       Date:  2021-05-11       Impact factor: 5.157

8.  TRIM7 inhibits enterovirus replication and promotes emergence of a viral variant with increased pathogenicity.

Authors:  Wenchun Fan; Katrina B Mar; Levent Sari; Ilona K Gaszek; Qiang Cheng; Bret M Evers; John M Shelton; Mary Wight-Carter; Daniel J Siegwart; Milo M Lin; John W Schoggins
Journal:  Cell       Date:  2021-05-31       Impact factor: 66.850

Review 9.  TRIM Proteins in Host Defense and Viral Pathogenesis.

Authors:  Maria I Giraldo; Adam Hage; Sarah van Tol; Ricardo Rajsbaum
Journal:  Curr Clin Microbiol Rep       Date:  2020-08-08

10.  LAMR1 restricts Zika virus infection by attenuating the envelope protein ubiquitination.

Authors:  Dingwen Hu; Yingchong Wang; Aixin Li; Qin Li; Caifeng Wu; Muhammad Adnan Shereen; Shanyu Huang; Kailang Wu; Ying Zhu; Wenbiao Wang; Jianguo Wu
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.